Rationale for the selection of an aerosol delivery system for gene delivery

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 19, Issue 3, 2006, Pages 372-384

  Lentz, Yvonne K ^a   Anchordoquy, Thomas J ^a   Lengsfeld, Corinne S ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b University of Denver   (United States)

Author keywords

Aerosols; DNA stability; Electrostatic spray; Gene delivery; Gene therapy; Jet nebulizer; Plasmid DNA; Pulmonary drug delivery; Shear; Vibrating mesh nebulizer

Indexed keywords

DNA; PLASMID DNA;

ARTICLE; COSMID; GENE THERAPY; GENETIC STABILITY; GENETIC TRANSFECTION; NEBULIZATION; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; SHEAR FLOW; ULTRASOUND;

ADMINISTRATION, INHALATION; AEROSOLS; DNA; ELECTROSTATICS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; PLASMIDS; TRANSFECTION;

EID: 33750932962     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2006.19.372     Document Type: Article

References (85)

1. Rajcani, J., T. Mosko, and I. Rezuchova. 2005. Current developments in viral DNA vaccines: shall they solve the unsolved? Rev. Med. Virol. 15:303-325.
2. Prud'homme, G.J. 2005. DNA vaccination against tumors. J. Gene Med. 7:3-17.
3. Mountain, A. 2000. Gene therapy: the first decade. Trends Biotechnol 18:119-128.
4. Liu, M., B. Acres, J.M. Balloul, N. Bizouarne, S. Paul, P. Slos, and P. Squiban. 2004. Gene-based vaccines and immunotherapeutics. Proc. Natl. Acad. Sci. U.S.A. 101:14567-14571.
5. Kinsey, B.M., C.L. Densmore, and P.M. Orson. 2005. Non-viral gene delivery to the lungs. Curr. Gene Ther. 5:181-194.
6. Anderson, W.F. 1995. Gene therapy. Sci. Am. 273:124-128.
7. Friedmann, T. 1997. Overcoming the obstacles to gene therapy. Sci. Am. 276:96-101.
8. Tuteja, R. 1999. DNA vaccines: a ray of hope. Crit. Rev. Biochem. Mol. Biol. 34:1-24.
9. Buchschacher G.L., Jr. and F. Wong-Staal. 2001. Approaches to gene therapy for human immunodeficiency virus infection. Hum. Gene Ther. 12:1013-1019.
10. Robbins P.D., C.H. Evans, and Y. Chernajovsky. 2003. Gene therapy for arthritis. Gene Ther. 10:902-911.
11. Douglas, J.T. 2003. Cancer gene therapy. Technol. Cancer Res. Treat. 2:51-64.
12. Bennett, W.D., J.S. Brown, K.L. Zeman, S.C. Hu, G. Scheuch, and K. Sommerer. 2002. Targeting delivery of aerosols to different lung regions. J. Aerosol Med. 15:179-188.
13. Schwarz, L.A., J.L. Johnson, M. Black, S.H. Cheng, M.E. Hogan, and J.C. Waldrep. 1996. Delivery of DNA-cationic liposome complexes by small-particle aerosol. Hum. Gene Ther. 7:731-741.
14. Stern, M., F. Sorgi, C. Hughes, N.J. Caplen, J.E. Browning, P.G. Middleton, D.C. Gruenert, S.J. Farr, L. Huang, D.M. Geddes, and E.W. Alton. 1998. The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. Gene Ther. 5:583-593.
15. Gautam, A., C.L. Densmore, B. Xu, and J.C. Waldrep. 2000. Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol. Ther. 2:63-70.
16. Gautam, A., J.C. Waldrep, and C.L Densmore. 2003. Aerosol gene therapy. Mol. Biotechnol. 23:51-60.
17. Deshpande, D., P. Blezinger, R. Pillai, J. Duguid, B. Freimark, and A. Rolland. 1998. Target specific optimization of cationic lipid-based systems for pulmonary gene therapy. Pharm. Res. 15:1340-1347.
18. Densmore, C.L., T.H. Giddings, J.C. Waldrep, B.M. Kinsey, and V. Knight. 1999. Gene transfer by guanidinium-cholesterol: dioleoylphosphatidyl- ethanolamine liposome-DNA complexes in aerosol. J. Gene Med. 1:251-264.
19. Densmore, C.L., P.M. Orson, B. Xu, B.M. Kinsey, J.C. Waldrep, P. Hua, B. Bhogal, and V. Knight. 2000. Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. Mol. Ther. 1:180-188.
20. Crook, K., G. McLachlan, B.J. Stevenson, and D.J. Porteous. 1996. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther. 3:834-839.
21. Birchall, J.C., I.W. Kellaway, and M. Gumbleton. 2000. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes. Int. J. Pharm. 197:221-231.
22. Rudolph, C., R.H. Muller, and J. Rosenecker. 2002. Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiency. J Gene Med. 4:66-74.
23. Fink, J.B. 2000. Metered-dose inhalers, dry powder inhalers, and transitions. Respir. Care 45:623-635.
24. Geller, D.E. 2002. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Respir. Care 47:1392-1404.
25. Terzano, C. 2001. Pressurized metered dose inhalers and add-on devices. Pulm. Pharmacol. Ther. 14:351-366.
26. Sacchetti, M., and M.M. Van Oort. 1996. Spray-drying and supercritical fluid particle generation techniques. In A.J. Hickey, ed. Inhalation Aerosols: Physical and Biological Basis for Therapy. Marcel Dekker, New York, 337-384.
27. Finlay, W.H. 2001. The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction. Academic Press, San Diego.
28. Rau, J.L. 2002. Design principles of liquid nebulization devices currently in use. Respir. Care 47:1257-1275.
29. Dhand, R. 2002. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir. Care 47:1406-1416.
30. Tang, K., and A. Gomez. 1994. Generation by electrospray of monodisperse water droplets for targeted drug-delivery by inhalation. J. Aerosol Sci. 25:1237-1249.
31. Li, S., W.C. Tseng, D.B. Stolz, S.P Wu, S.C. Watkins, and L. Huang. 1999. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 6:585-594.
32. Zabner, J., A.J. Fasbender, T. Moninger, K.A. Poellinger, and M.J. Welsh. 1995. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:18997-19007.
33. Pollard, H., J.S. Remy, G. Loussouarn, S. Demolombe, J.P Behr, and D. Escande. 1998. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273:7507-7511.
34. Oupicky, D., M. Ogris, K.A. Howard, P.R. Dash, K. Ulbrich, and L.W. Seymour. 2002. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol. Ther. 5:463-472.
35. Freimark, B.D., H.P. Blezinger, V.J. Florack, J.L. Nordstrom, S.D. Long, D.S. Deshpande, S. Nochumson, and K.L. Petrak. 1998. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J. Immunol. 160:4580-4586.
36. Ruiz, F.E., J.P. Clancy, M.A. Perricone, Z. Bebok, J.S. Hong, S.H. Cheng, D.P. Meeker, K.R. Young, R.A. Schoumacher, M.R. Weatherly, L. Wing, J.E. Morris, L. Sindel, M. Rosenberg, F.W. van Ginkel, J.R. McGhee, D. Kelly, R.K. Lyrene, and E.J. Sorscher. 2001. A clinical inflammatory syndrome attributable I to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. 12:751-761.
37. Tan, Y., F. Liu, Z. Li, S. Li, and L. Huang. 2001. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol. Ther. 3:673-682.
38. Norman, J., W. Denham, D. Denham, J. Yang, G. Carter, A. Abouhamze, C.L. Tannahill, S.L. MacKay, and L.L. Moldawer. 2000. Liposome-mediated, non-viral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation. Gene Ther. 7:1425-1430.
39. Scheule, R.K., J.A. St. George, R.G. Bagley, J. Marshall, J.M. Kaplan, G.Y. Akita, K.X. Wang, E.R. Lee, D.J. j Harris, C. Jiang, N.S. Yew, A.E. Smith, and S.H. Cheng. 1997. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8:689-707.
40. Tan, Y. and L. Huang. 2002. Overcoming the inflammatory toxicity of cationic gene vectors. J. Drug Target. 10:153-160.
41. Lengsfeld, C.S. and T.J. Anchordoquy. 2002. Shear-induced degradation of plasmid DNA. J. Pharm. Sci. 91:1581-1589.
42. Levy, M.S., R.D. O'Kennedy, P. Ayazi-Shamlou, and P. Dunnill. 2000. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends Biotechnol. 18:296-305.
43. Prazeres, D.M., G.N. Ferreira, G.A. Monteiro, C.L. Cooney, and J.M. Cabral. 1999. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol. 17:169-174.
44. Lentz, Y.K., L.R. Worden, T.J. Anchordoquy, and C.S. Lengsfeld. 2005. Effect of jet nebulization on DNA: identifying the dominant degradation mechanism and mitigation methods. J. Aerosol Sci. 36:973-990.
45. Alkins, S.A., K.M. Hurwitz, and A. Sierra. 2003. Effect of driving pressure and nebulizer model on aerosol output during intermittent delivery with a dosimeter. J. Aerosol Med. 15:1-6.
46. Fink, J.B., and J. Power. 2001. Comparison of a novel aerosol generator with a standard ultrasonic nebulizer designed for use during mechanical ventilation. Presented at the American Thoracic Society 97th International Conference, San Francisco.
47. Ram, A., and A. Kadim. 1970. Shear degradation of polymer solutions. J. Appl. Poly. Sci. 14:2145-2156.
48. Projan, S.J., S. Carleton, and R.P. Novick. 1983. Determination of plasmid copy number by fluorescence densitometry. Plasmid 9:182-190.
49. Middaugh, C.R., R.K. Evans, D.L. Montgomery, and D.R. Casimiro. 1998. Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87:130-146.
50. Labiris, N.R. and M.B. Dolovich. 2003. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol. 56:600-612.
51. Roche, N. and G.J. Huchon. 2000. Rationale for the choice of an aerosol delivery system. J. Aerosol Med. 13:393-404.
52. Pedersen, S. 1996. Inhalers and nebulizers: which to choose and why. Respir. Med. 90:69-77.
53. Dolovich, M.B. 2002. Assessing nebulizer performance. Respir. Care 47:1290-1301.
54. Edwards, D.A. and C. Dunbar. 2002. Bioengineering of therapeutic aerosols. Annu. Rev. Biomed. Eng. 4:93-107.
55. Groneberg, D.A., C. Witt, U. Wagner, K.F. Chung, and A. Fischer. 2003. Fundamentals of pulmonary drug delivery. Respir. Med. 97:382-387.
56. Le Brun, P.P., A.H. de Boer, H.G. Heijerman, and H.W. Frijlink. 2000. A review of the technical aspects of drug nebulization. Pharm. World Sci. 22:75-81.
57. Matthys, H. 1991. Nebulizer possibilities and limitations. J. Aerosol Med. 4:157-162.
58. Kimoto, H. and A. Taketo. 1996. Studies on electrotransfer of DNA into Escherichia coli: effect of molecular form of DNA. Biochim. Biophys. Acta. 1307:325-330.
59. Levy, M.S., L.J. Collins, S.S. Yim, J.M. Ward, N. Titchener-Hooker, P.A. Shamlou, and P. Dunnill. 1999. Effect of shear on plasmid DNA in solution. Bioprocess. Eng. 20:7-13.
60. Evans, R.K., Z. Xu, K.E. Bohannon, B. Wang, M.W. Bruner, and D.B. Volkin. 2000. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J. Pharm. Sci. 89:76-87.
61. Davison, P.P. 1959. The effect of hydrodynamic shear on the deoxyribonucleic acid from T2 and T4 bacteriophages. Proc. Natl. Acad. Sci. U.S.A. 45:1560-1568.
62. Levinthal, C. and P.F. Davison. 1961. Degradation of deoxyribonucleic acid under hydrodynamic shearing forces. J. Mol. Biol. 3:674-683.
63. Levy, M.S., L.A.S. Ciccolini, S.S.S. Yim, J.T. Tsai, N. Tichener-Hooker, P.A. Shamlou, and P. Dunnill. 1999. The effects of material properties and fluid flow intensity on plasmid DNA recovery during cell lysis. Chem. Eng. Sci. 54:3171-3178.
64. Meacle, F.J., R. Lander, P. Ayazi Shamlou, and N.J. Titchener-Hooker. 2004. Impact of engineering flow conditions on plasmid DNA yield and purity in chemical cell lysis operations. Biotechnol Bioeng. 87:293-302.
65. Stadler, J., R. Lemmens, and T. Nyhammar. 2004. Plasmid DNA purification. J. Gene Med. 6:S54-S66.
66. Maa, Y.F., P.A. Nguyen, and S.W. Hsu. 1998. Spray-drying of air-liquid interface sensitive recombinant human growth hormone. J. Pharm. Sci. 87:152-159.
67. Maa, Y.F. and C.C. Hsu. 1997. Protein denaturation by combined effect of shear and air-liquid interface. Biotechnol. Bioeng. 54:503-512.
68. Armster, S.Q., J.P. Delplanque, M. Rein, and E.J. Lavernia. 2002. Thermo-fluid mechanisms controlling droplet based materials processes. Int. Mater. Rev. 47:265-301.
69. Rein, M. 1993. Phenomena of liquid-drop impact on solid and liquid surfaces. Fluid Oyn. Res. 12:61-93.
70. Modell, J.H., S.T. Giammona, and J.H. Davis. 1967. Effect of chronic exposure to ultrasonic aerosols on the lung. Anesthesiology 28:680-688.
71. Stevens, H.R. and H.B. Albregt. 1966. Assessment of ultrasonic nebulization. Anesthesiology 27:648-653.
72. Wiedmann, T.S., and A. Ravichandran. 2001. Ultrasonic nebulization system for respiratory drug delivery. Pharm. Dev. Technol. 6:83-89.
73. Mercer, T.T. 1981. Production of therapeutic aerosols; principles and techniques. Chest 80:813-818.
74. Niven, R.W., K.L. Whitcomb, L. Shaner, A.Y. Ip, and O.B. Kinstler. 1995. The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF. Pharm. Res. 12:1343-1349.
75. Topp, M.N. 1973. Ultrasonic atomization-a photographic study of the mechanism of disintegration. J. Aerosol Sci. 4:17-25.
76. Mercer, T.T. 1973. Production and characterization of aerosols. Arch. Intern. Med. 131:39-50.
77. Bourne, N.K. 2002. On the collapse of cavities. Shock Waves 11:447-455.
78. Riesz, P., D. Berdahl, and C.L. Christman. 1985. Free radical generation by ultrasound in aqueous and non-aqueous solutions. Environ. Health Perspect. 64:233-252.
79. Thompson, L.H. and L.K. Doraiswamy. 1999. Sonochemistry: Science and engineering. Ind. Eng. Chem. Res. 38:1215-1249.
80. Adewuyi, Y.G. 2001. Sonochemistry: Environmental science and engineering applications. Ind. Eng. Chem. Res. 40:4681-1715.
81. Lentz, Y.K., T.J. Anchordoquy, and C.S. Lengsfeld. 2006. DNA acts as a nucleation site for transient cavitation in the ultrasonic nebulizer. J. Pharm. Sci. 95:607-619.
82. Dhand, R. 2004. New frontiers in aerosol delivery during mechanical ventilation. Respir. Care. 49:666-677.
83. Smart, J., R. Stangl, and E. Fritz. 2002. Touchspray technology: a preliminary in vitro evaluation of plasmid DNA of different size and topology. In Dalby, R., Byron, P., Peart, J., Farr, S.J., eds. Respiratory Drug Delivery VIII. Vol. 2. Davis Hoorwood International Publications, Tucson, AZ, 529-532.
84. Turner, S.W.P., M. Cabodi, and H.G. Craighead. 2002. Confinement-induced entropic recoil of single DNA molecules in a nanofluidic structure. Phys. Rev. Lett. 88, 12.
85. Cloupeau, M., and B. Prunet-Foch. 1990. Electrostatic spraying of liquids: main functioning modes. J. Electro. 25:165-184.